Celecoxib vs Pembrolizumab

Celecoxib vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Celecoxib and Pembrolizumab.

Mechanism of Action

Celecoxib: Selective COX-2 inhibitor.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Celecoxib — 11 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Celecoxib — C17H14F3N3O2S.

Molecular Weight: Celecoxib — 381.3730 g/mol.

Type: Celecoxib — Small molecule; Pembrolizumab — Antibody.